Canadians’ access to innovative medicines is already limited: Trump’s trade war will make it worse
Nigel S B Rawson | ABSTRACT – President Donald Trump has initiated an international trade
Implementing Primary Care Compensation Reform in Alberta: A Mixed-Methods Evaluation of Adoption Barriers and Enablers
Rebecca Zahn, Emily Johnston, Danica Hignell, Trevor Day, Brad Bahler | ABSTRACT – Canadian jurisdictions
Expanding Surgical Capacity Through Specialized Medical Centres: Evidence from Paediatric Surgery in Quebec
YANICK LABRIE | ABSTRACT – Background: Long surgical wait times remain a major policy challenge
Accroître la capacité chirurgicale par le recours aux centres médicaux spécialisés : le cas de la chirurgie pédiatrique au Québec
YANICK LABRIE | SOMMAIRE – Contexte : Malgré une hausse soutenue des dépenses de santé,
Does Health Canada achieve its performance standards for how long it should take to review new medicines?
NIGEL SB RAWSON | ABSTRACT – Health Canada is the national regulator of marketing authorization
From strategy to scale: a framework for operationalizing and evaluating dementia care coordination in Canada
Allison Alvares, Raymond Dominguez, Saskia Sivananthan, Alexandra Whate, Larry Chambers | ABSTRACT – In 2019, Canada
The impact of innovative medicines on healthcare costs in Canada 1990 to 2024: $20 billion cumulative annual variation in spending on patent drugs saved $70 billion in overall public healthcare expenditure.
Brett J Skinner, PhD | Founder and CEO, CHPI; Editor-in-Chief, CHPJ | ABSTRACT – Few